Topics

Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting 2019

08:07 EST 8 Nov 2019 | FinanzNachrichten

-- Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy -- -- Improved Markers of Bone and Renal Safety Also Seen with Vemlidy in Separate Ana...

Original Article: Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting 2019

NEXT ARTICLE

More From BioPortfolio on "Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting 2019"

Quick Search

Relevant Topics

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...